Capricor Therapeutics, Inc.
CAPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $15 | $10 | $35 |
| Short-Term Investments | $140 | $25 | $32 | $0 |
| Receivables | $10 | $10 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $1 | $1 |
| Total Curr. Assets | $163 | $51 | $43 | $36 |
| Property Plant & Equip (Net) | $7 | $8 | $7 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $7 | $8 | $7 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $170 | $59 | $50 | $41 |
| Liabilities | – | – | – | – |
| Payables | $8 | $6 | $5 | $0 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $18 | $0 |
| Other Curr. Liab. | $12 | $24 | $0 | $4 |
| Total Curr. Liab. | $21 | $31 | $24 | $4 |
| LT Debt | $1 | $1 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $9 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $3 | $3 | $3 |
| Total NC Liab. | $4 | $5 | $15 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $3 | $3 |
| Total Liabilities | $25 | $36 | $38 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$200 | -$159 | -$137 | -$108 |
| AOCI | $1 | $0 | $0 | $0 |
| Other Equity | $344 | $182 | $149 | $139 |
| Total Equity | $145 | $23 | $12 | $31 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $170 | $59 | $50 | $41 |
| Net Debt | -$10 | -$12 | -$7 | -$32 |